Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1810412rdf:typepubmed:Citationlld:pubmed
pubmed-article:1810412lifeskim:mentionsumls-concept:C2718284lld:lifeskim
pubmed-article:1810412lifeskim:mentionsumls-concept:C0023828lld:lifeskim
pubmed-article:1810412lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:1810412lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:1810412lifeskim:mentionsumls-concept:C0243126lld:lifeskim
pubmed-article:1810412lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:1810412lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:1810412lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:1810412lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:1810412pubmed:issue1lld:pubmed
pubmed-article:1810412pubmed:dateCreated1992-6-2lld:pubmed
pubmed-article:1810412pubmed:abstractTextN-acetyl-(2), N-caproyl-(3), N-capryl-(4) and N-palmitoyl-pyrazinamide (5) were synthesized by reacting pyrazinamide (1) with acetic anhydride to prepare (2), or by reacting (1) in chloroform with the corresponding acid chlorides to prepare (3-5). Products were identified by high resolution mass spectroscopy, elemental analysis, and 1H NMR. Melting points, enthalpies of fusion, solubility and octanol-water partition coefficients were determined. Hydrolysis of (2) indicated a pseudo first-order, pH-dependent degradation reaction. Apparent half life times of degradation ranged from 74.2 hours at pH 3 to 5.4 hours at pH 7.34. Derivative (5) was incorporated in liposomes consisting of soy phosphatidylcholine and dipalmitoylphosphatidylglycerol (7:3 molar ratio). The in vitro susceptibility of Mycobacterium avium-intracellulare (MAI) to the liposomal compound containing (5) was tested. MAI was susceptible to (5) at concentrations of 12.5-25 micrograms/ml, although MAI is not susceptible to the parent drug (1). Thus, a new class of antimycobacterial agents with physicochemical properties suitable for stable incorporation within liposomes and high antibiotic efficacy against MAI is presented.lld:pubmed
pubmed-article:1810412pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1810412pubmed:languageenglld:pubmed
pubmed-article:1810412pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1810412pubmed:citationSubsetIMlld:pubmed
pubmed-article:1810412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1810412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1810412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1810412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1810412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1810412pubmed:statusMEDLINElld:pubmed
pubmed-article:1810412pubmed:monthNovlld:pubmed
pubmed-article:1810412pubmed:issn1055-9612lld:pubmed
pubmed-article:1810412pubmed:authorpubmed-author:ErdosGGlld:pubmed
pubmed-article:1810412pubmed:authorpubmed-author:PrankerdR JRJlld:pubmed
pubmed-article:1810412pubmed:authorpubmed-author:SchreierHHlld:pubmed
pubmed-article:1810412pubmed:authorpubmed-author:UdeR HRHlld:pubmed
pubmed-article:1810412pubmed:authorpubmed-author:GuoX DXDlld:pubmed
pubmed-article:1810412pubmed:authorpubmed-author:Gonzalez-Roth...lld:pubmed
pubmed-article:1810412pubmed:authorpubmed-author:StraubL ELElld:pubmed
pubmed-article:1810412pubmed:issnTypePrintlld:pubmed
pubmed-article:1810412pubmed:volume8lld:pubmed
pubmed-article:1810412pubmed:ownerNLMlld:pubmed
pubmed-article:1810412pubmed:authorsCompleteYlld:pubmed
pubmed-article:1810412pubmed:pagination57-67lld:pubmed
pubmed-article:1810412pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:meshHeadingpubmed-meshheading:1810412-...lld:pubmed
pubmed-article:1810412pubmed:year1991lld:pubmed
pubmed-article:1810412pubmed:articleTitleLipophilic N-acylpyrazinamide derivatives: synthesis, physicochemical characterization, liposome incorporation, and in vitro activity against Mycobacterium avium-intracellulare.lld:pubmed
pubmed-article:1810412pubmed:affiliationDepartment of Pharmaceutics Drug Delivery Laboratory, University of Florida, Gainesville.lld:pubmed
pubmed-article:1810412pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1810412pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1810412pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:1810412pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1810412lld:pubmed